Form 8-K - Current report:
SEC Accession No. 0001437749-25-021959
Filing Date
2025-07-02
Accepted
2025-07-02 16:07:49
Documents
13
Period of Report
2025-06-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20250624_8k.htm   iXBRL 8-K 46995
  Complete submission text file 0001437749-25-021959.txt   177516

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA omer-20250627.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250627_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250627_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250627_pre.xml EX-101.PRE 11583
15 EXTRACTED XBRL INSTANCE DOCUMENT omer20250624_8k_htm.xml XML 2851
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 251100970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)